Welcome to use AbleSci to get your papers. Our English Version is under development. You can temporarily use Google to translate AbleSci. Quite easy! Thank you!

发布文献求助

已入深夜，您辛苦了！由于当前在线用户较少，发布求助请尽量完整地填写文献信息，科研通机器人24小时在线，伴您度过漫漫科研夜！祝你早点完成任务，早点休息，好梦！

qqq

Lv1

30 积分 2024-01-10 加入

最近求助
最近应助
互助留言

Does divergence in ESG ratings between domestic and foreign agencies impact firm valuation in China? 4天前 已完结
Board Connections and Trade Credit 6个月前 已完结
Firm's resilience to supply chain disruptions: Scale development and empirical examination 8个月前 已完结
Blockchain-supported business model design, supply chain resilience, and firm performance 8个月前 已完结
Conceptual underpinnings: theory selection in strategic management research 9个月前 已完结
Reporting regulation and corporate innovation 9个月前 已完结

Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial 8个月前 已采纳
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial 8个月前 已采纳
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial 8个月前 已采纳
EP.01.30 Beyond Smoking: Exploring Risk Factors for Lung Cancer in Women 8个月前 已采纳

没有进行任何互助留言

最近帖子
最近评论

没有发布任何帖子

没有发布任何评论

科研通是非营利科研互助平台，不忘初心，为科研助力

本站互助的所有文件仅供个人学习研究用，禁止任何人把求助的所得文献进行盈利或传播

皖ICP备2024041134号-1

皖公网安备34019202002308

科研通【文献互助QQ群】：如果您有特殊求助，或发布求助超过24小时未得到应助，可加群求助，群号：821889395【点击一键加群】

科研通【志愿服务QQ群】：如果您热爱文献互助，有热心愿意为更多人服务，请加入小伙伴群，点击申请加入

关注微信服务号

科研通